Table 1 Cumulative incidence of histologic transformation by lymphoma subtype.
Patients diagnosed between 2010–2015, n | Transformed cases between 2010–2020, n | Median follow-up among survivors, y (95% CI) | Cumulative incidence of HT, % | |
|---|---|---|---|---|
FL | 11934 | 662 | 7.75 (7.67–7.83) | 5.55 |
EMZL | 4070 | 66 | 7.58 (7.50–7.67) | 1.62 |
NMZL | 1779 | 72 | 7.83 (7.67–8.08) | 4.05 |
SMZL | 516 | 35 | 7.67 (7.42–8.08) | 6.78 |
LPL/WM | 1622 | 36 | 7.67 (7.50–7.83) | 2.22 |
